Group One Trading
IRLA

Group One Trading’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Group One Trading’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Sell
19,300
-12,046
-38% -$277K ﹤0.01% 3826
2026
Q1 		$636K Buy
31,346
+31,277
+45,329% +$6.28M ﹤0.01% 3118
2025
Q4 		$46.2K Buy
69
+19
+38% +$9.56K ﹤0.01% 5666
2025
Q3 		$16.3K Sell
50
-31
-38% -$10.3K ﹤0.01% 6851
2025
Q2 		$26.7K Sell
81
-7
-8% -$1.6K ﹤0.01% 6076
2025
Q1 		$23.3K Sell
88
-101
-53% -$30.8K ﹤0.01% 5714
2024
Q4 		$70.5K Buy
+189
New +$56.8K ﹤0.01% 4807
2023
Q4 		– Sell
-223
Closed -$49.8K – 8048
2023
Q3 		$49.8K Sell
223
-16
-7% -$4.18K ﹤0.01% 5101
2023
Q2 		$71.7K Sell
239
-28
-10% -$8.72K ﹤0.01% 4950
2023
Q1 		$83.1K Buy
267
+144
+117% +$28.2K ﹤0.01% 4455
2022
Q4 		$15.6K Sell
123
-1
-0.8% -$167 ﹤0.01% 5759
2022
Q3 		$33K Sell
124
-14
-10% -$5.33K ﹤0.01% 5733
2022
Q2 		$61K Sell
138
-617
-82% -$436K ﹤0.01% 5405
2022
Q1 		$934K Sell
755
-2,707
-78% -$3.68M ﹤0.01% 3156
2021
Q4 		$8.74M Buy
3,462
+3,031
+703% +$18.5M 0.01% 1210
2021
Q3 		$7.89M Buy
431
+309
+253% +$4.91M 0.01% 1273
2021
Q2 		$1.29M Buy
122
+27
+28% +$226K ﹤0.01% 3116
2021
Q1 		$685K Buy
95
+89
+1,483% +$640K ﹤0.01% 3669
2020
Q4 		$33K Buy
6
+5
+500% +$44.3K ﹤0.01% 5250
2020
Q3 		$5K Buy
+1
New +$9.1K ﹤0.01% 5648

Other funds holding IRLA

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading's IRLA Position: Q1 2026 in Review

Group One Trading sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q1 2026, closing a stake of 702 shares — an estimated $141K sold.

Group One Trading first reported a position in IRLA in Q4 2020 and held it in 11 quarters. The position peaked at $647K in Q1 2022. 43 funds tracked by Wall St. Rank hold IRLA as of Q1 2026.

  • Group One Trading reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 702 IRulya Therapeutics Inc. Common Stock shares in Q1 2026, an estimated $141K.
  • Group One Trading first reported a position in IRulya Therapeutics Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Group One Trading's IRulya Therapeutics Inc. Common Stock position peaked at $647K in Q1 2022.
  • 43 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.